Yu‐Chen Cheng

628 citations
33 papers · 504 indexed · h-index 13
Topics
Ubiquitin and proteasome pathways (4 papers)Magnolia and Illicium research (3 papers)Cancer, Lipids, and Metabolism (3 papers)
Partner nations
TaiwanChinaUnited States

In The Last Decade

Yu‐Chen Cheng

32 papers receiving 500 citations

Peers

Yu‐Chen Cheng
Comparison fields: 5 of 91
  • Molecular Biology 227
  • Rehabilitation 58
  • Pharmacology 57
  • Cancer Research 57
  • Cell Biology 55
Replace Mi‐Gi Lee with:
Mi‐Gi Lee South Korea
Hsin‐Ching Sung Taiwan
Rohinton S. Tarapore United States
Jianqiao Zhong China
Dabin Choi South Korea
Dorota M. Radomska-Leśniewska Poland
Dehai Xian China
Chen-Chen Lee Taiwan
Miki Tsujita‐Kyutoku Japan
Maria Garmyn Belgium
Yu‐Chen Cheng relative to Mi‐Gi Lee South Korea Mi‐Gi Lee's profile →
Citations per field
00.5×
Mi‐Gi Lee · 1×
Citations per year

Countries citing papers authored by Yu‐Chen Cheng

Since Specialization
Citations

This map shows the geographic impact of Yu‐Chen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Chen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Chen Cheng more than expected).

Fields of papers citing papers by Yu‐Chen Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Chen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Chen Cheng. The network helps show where Yu‐Chen Cheng may publish in the future.

Co-authorship network of co-authors of Yu‐Chen Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Chen Cheng. A scholar is included among the top collaborators of Yu‐Chen Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Chen Cheng. Yu‐Chen Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 3
4 2
5 0
6 1
7 6
8 5
9 19
10 3
11 11
12 14
13 42
14 7
15 18
16 4
17 54
18 27
19 35
20 10

About Yu‐Chen Cheng

Yu‐Chen Cheng is a scholar working on Structural Biology, Rehabilitation and Cancer Research, having authored 33 papers that have together received 504 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Magnolia and Illicium research (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Rehabilitation (58 citations), Pharmacology (43 citations) and Biochemistry (29 citations). Yu‐Chen Cheng has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Ying Chen, Dueng‐Yuan Hueng, Wen‐Chiuan Tsai, Pen‐hsiu Grace Chao, Yi‐Hsuan Lin, Youming Ding, Gwo‐Jang Wu, Yu‐Chiang Hung, Wen‐Tai Li and Jia‐You Fang. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Applied Microbiology and Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026